Ohio Administrative Code › Title 3745 - Ohio Environmental Protection Agency › Chapter 3745-266 - Disposal Standards › Section 3745-266-509 - Shipping potentially creditable hazardous waste pharmaceuticals from a healthcare facility or a reverse distributor to a reverse distributor

Current through all regulations passed and filed through July 1, 2024
(A)
								Shipping potentially creditable hazardous waste
			 pharmaceuticals. A healthcare facility or a reverse distributor who transports
			 or offers for transport potentially creditable hazardous waste pharmaceuticals
			 off-site to a reverse distributor shall comply with all applicable U.S.
			 department of transportation (DOT) regulations in 49 C.F.R. Parts 171 to 180
			 for any potentially creditable hazardous waste pharmaceutical that meets the
			 definition of "hazardous material" in
			 49 C.F.R.
			 171.8. For purposes of the DOT regulations, a
			 material is considered a hazardous waste if the material is subject to the
			 hazardous waste manifest requirements of U.S. EPA specified in 40 C.F.R. Part
			 262. Because a potentially creditable hazardous waste pharmaceutical does not
			 require a manifest, the hazardous waste pharmaceutical is not considered
			 hazardous waste under the DOT regulations.
(B)
								Delivery
			 confirmation. Upon receipt of each shipment of potentially creditable hazardous
			 waste pharmaceuticals, the receiving reverse distributor shall provide
			 confirmation (paper or electronic) to the healthcare facility or reverse
			 distributor that initiated the shipment that the shipment of potentially
			 creditable hazardous waste pharmaceuticals has arrived at the potentially
			 creditable hazardous waste pharmaceuticals' destination and is under the
			 custody and control of the reverse distributor.
(C)
								Procedures for
			 when delivery confirmation is not received within thirty-five calendar days. If
			 a healthcare facility or reverse distributor initiates a shipment of
			 potentially creditable hazardous waste pharmaceuticals to a reverse distributor
			 and does not receive delivery confirmation within thirty-five calendar days
			 after the date that the shipment of potentially creditable hazardous waste
			 pharmaceuticals was sent, the healthcare facility or reverse distributor that
			 initiated the shipment shall contact the carrier and the intended recipient
			 (i.e., the reverse distributor) promptly to report that the delivery
			 confirmation was not received and to determine the status of the potentially
			 creditable hazardous waste pharmaceuticals.
(D)
								Exporting
			 potentially creditable hazardous waste pharmaceuticals. A healthcare facility
			 or reverse distributor that sends potentially creditable hazardous waste
			 pharmaceuticals to a foreign destination shall comply with the applicable
			 sections of 40 C.F.R. Part 262 subpart H, except the manifesting requirement of
			 40 C.F.R.
			 262.83(c), in addition to
			 paragraphs (A) to (C) of this rule.
(E)
								Importing
			 potentially creditable hazardous waste pharmaceuticals. Any person that imports
			 potentially creditable hazardous waste pharmaceuticals into Ohio is subject to
			 paragraphs (A) to (C) of this rule in lieu of 40 C.F.R. Part 262 subpart H.
			 Immediately after the potentially creditable hazardous waste pharmaceuticals
			 enter Ohio, the hazardous waste pharmaceuticals are subject to all applicable
			 requirements of rules 3745-266-500 to 3745-266-510 of the Administrative
			 Code.
[Comment: For dates of non-regulatory
				government publications, publications of recognized organizations and
				associations, federal rules, and federal statutory provisions referenced in
				this rule, see rule
				3745-50-11
				of the Administrative Code titled "Incorporated by reference."]